Pds Biotechnology Corp Stock Last Dividend Paid
EU6 Stock | EUR 1.43 0.03 2.14% |
PDS Biotechnology Corp fundamentals help investors to digest information that contributes to PDS Biotechnology's financial success or failures. It also enables traders to predict the movement of PDS Stock. The fundamental analysis module provides a way to measure PDS Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PDS Biotechnology stock.
PDS |
PDS Biotechnology Corp Company Last Dividend Paid Analysis
PDS Biotechnology's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, PDS Biotechnology Corp has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
PDS Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PDS Biotechnology's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PDS Biotechnology could also be used in its relative valuation, which is a method of valuing PDS Biotechnology by comparing valuation metrics of similar companies.PDS Biotechnology is currently under evaluation in last dividend paid category among its peers.
PDS Fundamentals
Return On Equity | -0.49 | |||
Return On Asset | -0.25 | |||
Current Valuation | 189.69 M | |||
Shares Outstanding | 28.89 M | |||
Shares Owned By Insiders | 14.20 % | |||
Shares Owned By Institutions | 23.77 % | |||
Price To Earning | 23.42 X | |||
Price To Book | 5.63 X | |||
EBITDA | (21.43 M) | |||
Net Income | (16.92 M) | |||
Cash And Equivalents | 74.75 M | |||
Cash Per Share | 2.63 X | |||
Total Debt | 552.98 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 19.22 X | |||
Book Value Per Share | 1.65 X | |||
Cash Flow From Operations | (12.49 M) | |||
Earnings Per Share | (0.91) X | |||
Price To Earnings To Growth | (0.29) X | |||
Target Price | 19.71 | |||
Number Of Employees | 22 | |||
Beta | 1.91 | |||
Market Capitalization | 206 M | |||
Total Asset | 67.2 M | |||
Net Asset | 67.2 M |
About PDS Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PDS Biotechnology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PDS Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PDS Biotechnology Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in PDS Stock
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.